Skip to content
Clinical Trials – home
FranceBack to France

Clinical trials in Clamart – page 2

60 clinical trials in Clamart, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
Clamart at a glance
60
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

60 trials in Clamart

Open in trial search

Study on Nifedipine for Managing Preterm Premature Rupture of Membranes (PPROM) in Pregnant Women Before 34 Weeks

Registered drug
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Nifedipine
  • Sponsor:Assistance Publique Hopitaux De Paris

Study on Isatuximab for Treating Pure Red Cell Aplasia in Patients with Major ABO Mismatch After Stem Cell Transplantation

Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Isatuximab
  • Sponsor:Assistance Publique Hopitaux De Paris

Placenta praevia+1

Recruiting

Study on Tranexamic Acid to Prevent Blood Loss in Women with Placenta Previa Undergoing Cesarean Delivery

Registered drug
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Tranexamic Acid
  • Sponsor:Centre Hospitalier Universitaire De Bordeaux

Study to Test if Zelpultide Alfa Helps Prevent Lung Disease in High-Risk Premature Babies

Investigational
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Recombinant Human Surfactant Protein-D
  • Sponsor:Airway Therapeutics Inc.

Study Comparing Clarithromycin and Azithromycin for Treating Mycobacterium Avium Complex Lung Infections in Adults

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Azithromycin
  • Sponsor:Centre Hospitalier Universitaire Amiens Picardie

Rectal cancer

Recruiting

Study comparing preoperative drug combination with irinotecan, fluorouracil, calcium folinate and oxaliplatin for patients with locally advanced resectable rectal cancer

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Assistance Publique Hopitaux De Paris

Study on the Effect of Post-Surgery Chemotherapy with Irinotecan and Drug Combination for Patients with Colorectal Cancer and Liver Metastases

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Assistance Publique Hopitaux De Paris

Evaluation of Bevacizumab in Patients with Brain Radionecrosis After Radiation Treatment for Brain Metastases

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Institut De Cancerologie De L Ouest

Colon cancer

Recruiting

Study on the Effectiveness of Chemotherapy with Folinic Acid, Fluorouracil, and Irinotecan for Patients with Stage III Colon Cancer After Surgery

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Centre Hospitalier Universitaire De Dijon

Study on Gene Therapy GNT0003 for Patients with Severe Crigler-Najjar Syndrome Requiring Phototherapy

Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Abiraterone Acetate
  • Sponsor:Genethon

Study of Intranasal Sufentanil and Intravenous Morphine for Severe Sickle Cell Pain Crisis in Children

Registered drug
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Sodium Chloride
  • Sponsor:Assistance Publique Hopitaux De Paris

Study Comparing CPX-351 and Chemotherapy for Patients with New Intermediate or High-Risk Acute Myeloid Leukemia

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cytarabine
  • Sponsor:Centre Hospitalier Universitaire De Nice

Other cities in France

The busiest research cities in the country

All 382 cities in France

Clinical research in Clamart

What the registry says about research in the country

01 Oncology/Hematology

Innovative research focusing on multiple myeloma treatment strategies, including studies evaluating novel combinations like elranatamab-lenalidomide and maintenance therapies. Several trials in Paris are exploring advanced treatments for non-small cell lung cancer, particularly in elderly patients.

  • Multiple Myeloma Therapies
  • Lung Cancer Treatments
  • Colorectal Cancer Research

Additional studies address breast cancer preservation and brain metastases treatment approaches.

02 Rare Diseases & Genetic Disorders

Groundbreaking research in gene therapy for Crigler-Najjar syndrome and innovative treatments for glycogen storage disease type 1a. Studies focus on developing targeted therapeutic approaches for these rare conditions.

  • Genetic Disease Treatments
  • Metabolic Disorders
  • Novel Gene Therapies

Emphasis on developing personalized treatment approaches for rare genetic conditions.

03 Critical Care & Infectious Diseases

Studies examining corticosteroid insufficiency in critical illness and prevention of C. difficile infections in transplant patients. Research includes innovative approaches to acute osteomyelitis treatment in children.

  • Critical Care Interventions
  • Infection Prevention
  • Pediatric Treatments

Focus on improving patient outcomes in critical care settings and infection management.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.